GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GSK GlaxoSmithKline PLC

Market Closed 06-05 16:00:00 EDT

51.52

+0.25

+0.49%

盘后51.52

+0.000.00%

19:39 EDT

High51.97	Low51.27	Vol4.05M
Open51.42	D1 Closing51.27	Amplitude1.38%
Mkt Cap104.37B	Tradable Cap100.30B	Total Shares2.03B
T/O209.27M	T/O Rate0.21%	Tradable Shares1.95B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"GlaxoSmithKline PLC","latestPrice":51.52,"timestamp":1780689600000,"preClose":51.27,"halted":0,"volume":4048091,"hourTrading":{"tag":"盘后","latestPrice":51.52,"preClose":51.52,"latestTime":"19:39 EDT","volume":14224,"amount":732829.548,"timestamp":1780702787299,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0048761458942851565,"floatShares":1946891708,"shares":2025750558,"eps":3.736205,"marketStatus":"Market Closed","change":0.25,"latestTime":"06-05 16:00:00 EDT","open":51.42,"high":51.97,"low":51.265,"amount":209266926.48838302,"amplitude":0.013751,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.736205,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":7,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":51.27,"dividendRate":0.035054,"preHourTrading":{"tag":"盘前","latestPrice":51.42,"preClose":51.27,"latestTime":"09:29 EDT","volume":11317,"amount":581896.71381,"timestamp":1780666199999,"change":0.15,"changeRate":0.002926,"amplitude":0.01403},"postHourTrading":{"tag":"盘后","latestPrice":51.52,"preClose":51.52,"latestTime":"19:39 EDT","volume":14224,"amount":732829.548,"timestamp":1780702787299,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1566416453853663,"impliedVol":0.2586,"impliedVolPercentile":0.1952},"requestUrl":"/m/hq/s/GSK/wiki","defaultTab":"wiki","newsList":[{"id":"2641141238","title":"GSK’s New Pneumococcal Shot Reaches Key Milestone in Midlife Adult Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2641141238","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641141238?lang=en_us&edition=fundamental","pubTime":"2026-06-06 00:31","pubTimestamp":1780677068,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has completed a Phase 1 trial titled “A Phase 1, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-pneumococcal-shot-reaches-key-milestone-in-midlife-adult-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-pneumococcal-shot-reaches-key-milestone-in-midlife-adult-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4585","BK4588","BK4007","LU1829250122.USD","GSKH","BK4532","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641538141","title":"GSK Climbs Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2641538141","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641538141?lang=en_us&edition=fundamental","pubTime":"2026-06-06 00:09","pubTimestamp":1780675740,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares rose 1.89% to GBP19.38 Friday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index  rising 0.07% to 10,368.05.GSK PLC closed 15.07% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 5.2 million, compared to the 50-day average of 8.0 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109935081","title":"Movement Alert｜GSK Rises 3.01% in Regular Trading, Positive Phase III Data for Hepatitis B Functional Cure Drug and Accelerated China Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1109935081","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109935081?lang=en_us&edition=fundamental","pubTime":"2026-06-05 03:54","pubTimestamp":1780602852,"startTime":"0","endTime":"0","summary":"On June 5, GSK rose 3.01% in regular trading, trading at $51.22/share, with trading volume of $170 million.The move was driven by positive Phase III clinical data for Bepirovirsen, GSK's hepatitis B...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640821661","title":"GlaxoSmithKline (GSK) Gets a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2640821661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640821661?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:25","pubTimestamp":1780521915,"startTime":"0","endTime":"0","summary":"Jefferies analyst Michael Leuchten maintained a Buy rating on GlaxoSmithKline today and set a price target of £25.00. According to TipRanks, Leucht...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","BK4007","BK4532","BK4585","GSKH","BK4588","GSK","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640718183","title":"GSK Rallies Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2640718183","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640718183?lang=en_us&edition=fundamental","pubTime":"2026-06-04 00:09","pubTimestamp":1780502940,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of GSK PLC  rallied 1.70% to GBP18.52 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index  falling 0.40% to 10,332.30.GSK PLC closed 18.87% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 5.0 million, compared to the 50-day average of 8.1 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640950348","title":"GSK boosts treasury stock as buyback lifts voting share base","url":"https://stock-news.laohu8.com/highlight/detail?id=2640950348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640950348?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:16","pubTimestamp":1780323389,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK has continued its share buyback programme, repurchasing just under 1.25 million or...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-as-buyback-lifts-voting-share-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-as-buyback-lifts-voting-share-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMF","US5Y.BOND","US30Y.BOND","LU1829250122.USD","TLTW","US6M.BOND","US3Y.BOND","GSK","TLT","BK4007","BK4585","GSK.UK","US12M.BOND","BK4532","US2Y.BOND","US10Y.BOND","GSKH","BK4588","US7Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640953748","title":"J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640953748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640953748?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:36","pubTimestamp":1780310193,"startTime":"0","endTime":"0","summary":"In a report released today, Zain Ebrahim from J.P. Morgan maintained a Sell rating on GlaxoSmithKline, with a price target of £17.00. According to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-their-sell-rating-for-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-their-sell-rating-for-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640930291","title":"GSK Emerges as Unexpected Winner From American Oncology Conference -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2640930291","media":"Dow Jones","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640930291?lang=en_us&edition=fundamental","pubTime":"2026-06-01 17:53","pubTimestamp":1780307580,"startTime":"0","endTime":"0","summary":"0953 GMT - U.K. drugmaker GSK came out as an unexpected winner from a big U.S. oncology conference, Jefferies analysts say in a note. Early-stage data for GSK's drug candidate IDRx-42 presented at the American Society of Clinical Oncology's annual meeting showed potential as a first-line treatment for gastrointestinal cancer, Jefferies says. Moreover, updates from rivals on new ovarian-cancer drugs didn't top those of GSK's own candidate Mo-Rez, the analysts say. Competition in the market for drugs to treat ovarian cancer resistant to platinum-based chemotherapy is heating up, they add. GSK's Mo-Rez and NaPi2b--developed by Tubulis, which was recently acquired by Gilead Sciences--might be setting the bar for the disease, while AstraZeneca's Puxi-Sam doesn't look as competitive, according to Jefferies. GSK shares fall 0.3%. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","BK4107","BK4007","BK4532","GSKH","BK4588","BK4117","AFG","GSK","GSK.UK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639606232","title":"Analysts Conflicted on These Healthcare Names: GlaxoSmithKline (GB:GSK) and C4 Therapeutics (CCCC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2639606232","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639606232?lang=en_us&edition=fundamental","pubTime":"2026-05-30 17:02","pubTimestamp":1780131770,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on GlaxoSmithKline (GB:GSK) and C4 Therapeutics (CCCC). GlaxoSmithKl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-glaxosmithkline-gbgsk-and-c4-therapeutics-cccc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-glaxosmithkline-gbgsk-and-c4-therapeutics-cccc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU1829250122.USD","BK4007","BK4139","BK4532","BK4588","GSKH","HCSG","LU0128526141.USD","GSK","CCCC","LU0029874061.USD","GSK.UK","BK4581","XBI","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639679680","title":"GSK Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2639679680","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639679680?lang=en_us&edition=fundamental","pubTime":"2026-05-30 00:08","pubTimestamp":1780070880,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares slipped 1.90% to GBP18.82 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index  falling 0.16% to 10,409.28.GSK PLC closed 17.55% below its 52-week high of GBP22.82, which the company reached on February 18th.Trading volume totaled 16.9 million, compared to the 50-day average of 8.0 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639693623","title":"GlaxoSmithKline (GSK) Gets a Hold from UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2639693623","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639693623?lang=en_us&edition=fundamental","pubTime":"2026-05-29 17:00","pubTimestamp":1780045236,"startTime":"0","endTime":"0","summary":"UBS analyst Matthew Weston maintained a Hold rating on GlaxoSmithKline today and set a price target of p1,940.00. According to TipRanks, Weston is ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","BK4532","BK4588","LU3187612489.SGD","UBS","BK4585","GSKH","LU1863844749.USD","BK4007","BK4118","IE0034235071.USD","LU1863844665.USD","GSK.UK","GSK","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136878581","title":"SBP GROUP (01177) Rises Over 4% as Bepirovirsen Co-developed with GlaxoSmithKline PLC to Unveil Two Phase III Clinical Data at EASL 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1136878581","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136878581?lang=en_us&edition=fundamental","pubTime":"2026-05-29 14:38","pubTimestamp":1780036715,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) rose over 4%, up 3.95% at the time of writing, trading at HK$5 with a turnover of HK$428 million. On May 29, SBP GROUP announced that Bepirovirsen, co-developed by its subsidiary,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","IE00BZ08YS42.EUR","GSKH","BK4588","BK4532","BK4007","GSK","IE00BZ08YT58.USD","III","01177","BK4134","BK1515","IE00BZ08YR35.GBP","BK1589","BK1191","BK1521","GSK.UK","BK4585","LU1829250122.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639612379","title":"Sino Biopharm, GSK Report Pivotal Phase III Success for Hepatitis B Drug Bepirovirsen","url":"https://stock-news.laohu8.com/highlight/detail?id=2639612379","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639612379?lang=en_us&edition=fundamental","pubTime":"2026-05-29 07:38","pubTimestamp":1780011524,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical ( ($HK:1177) ) has provided an update. Sino Biopharmaceutical said its subsidiary Chia Tai Tianqing and partner GSK have rep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-gsk-report-pivotal-phase-iii-success-for-hepatitis-b-drug-bepirovirsen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-gsk-report-pivotal-phase-iii-success-for-hepatitis-b-drug-bepirovirsen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","LU1829250122.USD","BK4588","BK4007","BK4134","BK4585","GSK","III","GSK.UK","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639697287","title":"GSK’s mRNA Flu Vaccine Trial Reaches Key Phase 2 Milestone, Eyeing Next-Gen Seasonal Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2639697287","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639697287?lang=en_us&edition=fundamental","pubTime":"2026-05-29 00:30","pubTimestamp":1779985844,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK’s latest update covers a Phase 2a trial titled “A Phase 2a Randomiz...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-mrna-flu-vaccine-trial-reaches-key-phase-2-milestone-eyeing-next-gen-seasonal-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-mrna-flu-vaccine-trial-reaches-key-phase-2-milestone-eyeing-next-gen-seasonal-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GSKH","LU1829250122.USD","BK4007","BK4588","GSK","BK4532","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698965","title":"J.P. Morgan Keeps Their Sell Rating on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698965","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698965?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:59","pubTimestamp":1779969568,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Zain Ebrahim maintained a Sell rating on GlaxoSmithKline today and set a price target of £17.00. According to TipRanks, Ebrahim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-keeps-their-sell-rating-on-glaxosmithkline-gsk-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-keeps-their-sell-rating-on-glaxosmithkline-gsk-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638667291","title":"GSK Trial Data Show Functional Cure Rates For Hepatitis B Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2638667291","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638667291?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:05","pubTimestamp":1779966331,"startTime":"0","endTime":"0","summary":"GSK's  pooled data from two phase 3 clinical trials showed that experimental medicine bepirovirsen achieved a 19% functional cure response rate in individuals with chronic hepatitis B, the drugmaker said Thursday.The therapy reached a 26% cure rate among patients exhibiting lower baseline viral activity compared with no cures in the placebo group, the company said.GSK said it anticipates regulatory approvals in Q3.An exploratory evaluation also indicated nearly half of the participants maintained low surface antigen levels a year after finishing the regimen, GSK said.The medication demonstrated a tolerable safety profile during the trials, with common side effects including temporary liver enzyme elevation and localized injection site pain, GSK said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","GSKH","LU1829250122.USD","BK4007","BK4588","GSK","BK4532","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638696556","title":"Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2638696556","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638696556?lang=en_us&edition=fundamental","pubTime":"2026-05-28 17:21","pubTimestamp":1779960078,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals (IONS) partner GSK (GSK) announced data for bepirovirsen, an investigational antisense oligonucleotide for the treatment of c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ionis-partner-gsk-reports-b-well-1-b-well-2-trials-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ionis-partner-gsk-reports-b-well-1-b-well-2-trials-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","GSKH","LU1829250122.USD","BK4532","IONS","BK4139","BK4007","BK4588","GSK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638263665","title":"GSK Says Hepatitis B Drug Candidate Cured Some Patients in Late-Stage Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2638263665","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638263665?lang=en_us&edition=fundamental","pubTime":"2026-05-28 16:39","pubTimestamp":1779957540,"startTime":"0","endTime":"0","summary":"GSK said a drug candidate for hepatitis B helped nearly a fifth of patients who enrolled in two late-stage clinical trials achieve a functional cure.The U.K. drugmaker on Thursday released results from two phase 3 trials for the drug, bepirovirsen, which showed 19% of hepatitis B patients achieved a functional cure response rate in the overall study population after a six-month treatment. The drug delivered a functional cure rate of 26% in a smaller group of patients with lower viral activity, the company said.GSK is looking to speed up the launch of the medicines it has in the pipeline, as part of GSK Chief Executive Luke Miels' plan to offset upcoming patent expirations. Miels singled out bepirovirsen in a recent earnings call, saying it would materially change the treatment of hepatitis B.Hepatitis B is a serious liver infection, which can lead to liver damage, cancer and death. GSK said the drug has potential to redefine the treatment of a disease for which the current standard of ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSKH","BK4588","SSI","LU1829250122.USD","BK4585","BK4007","GSK","BK4532","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638766503","title":"GSK’s bepirovirsen delivers landmark functional cure rates in chronic hepatitis B phase III trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2638766503","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638766503?lang=en_us&edition=fundamental","pubTime":"2026-05-28 16:32","pubTimestamp":1779957142,"startTime":"0","endTime":"0","summary":"An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK reported pivotal phase III data showing its investigational antisense oligonucle...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-bepirovirsen-delivers-landmark-functional-cure-rates-in-chronic-hepatitis-b-phase-iii-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-bepirovirsen-delivers-landmark-functional-cure-rates-in-chronic-hepatitis-b-phase-iii-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","BK4588","BK4007","GSK","GSKH","III","BK4585","BK4134","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638634636","title":"Positive Report for GlaxoSmithKline (GSK) from Kepler Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2638634636","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638634636?lang=en_us&edition=fundamental","pubTime":"2026-05-28 15:55","pubTimestamp":1779954956,"startTime":"0","endTime":"0","summary":"In a report released on May 26, Nicolas Pauillac from Kepler Capital upgraded GlaxoSmithKline to a Buy, with a price target of p2,516.00. According...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-report-for-glaxosmithkline-gsk-from-kepler-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-report-for-glaxosmithkline-gsk-from-kepler-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","GSK","BK4007","BK4588","BK4585","BK4532","GSKH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":0.0194},{"period":"1month","weight":0.0196},{"period":"3month","weight":-0.0549},{"period":"6month","weight":0.0642},{"period":"1year","weight":0.252},{"period":"ytd","weight":0.0506}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.586957,"avgChangeRate":0.013809},{"month":2,"riseRate":0.478261,"avgChangeRate":0.001243},{"month":3,"riseRate":0.608696,"avgChangeRate":0.019112},{"month":4,"riseRate":0.659574,"avgChangeRate":0.030828},{"month":5,"riseRate":0.404255,"avgChangeRate":-0.008644},{"month":6,"riseRate":0.595745,"avgChangeRate":0.009855},{"month":7,"riseRate":0.543478,"avgChangeRate":0.003945},{"month":8,"riseRate":0.586957,"avgChangeRate":0.005806},{"month":9,"riseRate":0.521739,"avgChangeRate":0.005973},{"month":10,"riseRate":0.521739,"avgChangeRate":0.013062},{"month":11,"riseRate":0.478261,"avgChangeRate":0.009917},{"month":12,"riseRate":0.608696,"avgChangeRate":0.014188}],"exchange":"NYSE","name":"GlaxoSmithKline PLC","nameEN":"GlaxoSmithKline PLC","securityTypeName":"DR","adrRate":"1:2"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlaxoSmithKline PLC,GSK,GlaxoSmithKline PLC股票,GlaxoSmithKline PLC股票老虎,GlaxoSmithKline PLC股票老虎国际,GlaxoSmithKline PLC行情,GlaxoSmithKline PLC股票行情,GlaxoSmithKline PLC股价,GlaxoSmithKline PLC股市,GlaxoSmithKline PLC股票价格,GlaxoSmithKline PLC股票交易,GlaxoSmithKline PLC股票购买,GlaxoSmithKline PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}